SkyAI, Inc. (SKYA)
About SkyAI, Inc.
SkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $204.1K
- Net income
- -$282.5M
- Total assets
- $269.1M
- Market cap
- $58.8M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $58.8M
- Shares outstanding
- 20.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 14, 2022
SkyAI, Inc. (SKYA) Stock Price
- Reported a net loss of $282.5M in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SkyAI, Inc..
Write a review
News about SkyAI, Inc.
News & sentiment via Polygon.io
SkyAI, Inc.: frequently asked questions
Is SkyAI, Inc. an American company?
SkyAI, Inc. is a US-based company headquartered in Melville, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is SkyAI, Inc. headquartered?
SkyAI, Inc. is headquartered in Melville, New York, United States.
Is SkyAI, Inc. publicly traded?
Yes — SkyAI, Inc. is a publicly traded company. Its stock trades under the ticker symbol SKYA on the NASDAQ.
What does SkyAI, Inc. do?
SkyAI, Inc. is an American Medical Devices company in the Health & Beauty sector.
